Ain Pharmaciez Inc (9627)

Tokyo

Currency in JPY

Disclaimer

5,191.0

-73.0(-1.39%)

Closed02:00:29

Fair Value

Day's Range

5,191.0

5,262.0

52 wk Range

4,023.0

6,285.0

9627 Income Statement

Featured here, the Income Statement (earnings report) for Ain Pharmaciez Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

30/04

2016

30/04

2017

30/04

2018

30/04

2019

30/04

2020

30/04

2021

30/04

2022

30/04

2023

30/04

2024

30/04

Total Revenues

292,615

297,305

316,247

358,742

399,824

Total Revenues Growth

+6.18%

+1.6%

+6.37%

+13.44%

+11.45%

Cost Of Revenues

245,753

251,150

266,275

305,043

340,301

Gross Profit

46,862

46,155

49,972

53,699

59,523

Gross Profit Growth

+3.3%

-1.51%

+8.27%

+7.46%

+10.85%

Gross Profit Margin %

16.01%

15.52%

15.8%

14.97%

14.89%

Other Operating Expenses, Total

30,793

35,404

34,838

37,742

39,186

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+5.03%	+14.97%	-1.6%	+8.34%	+3.83%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	23,560	28,030	27,884	29,734	30,467
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,225	1,951	1,587	2,222	2,558

Operating Income

16,069

10,751

15,134

15,957

20,337

Operating Income Growth

+0.16%

-33.09%

+40.77%

+5.44%

+27.45%

EBIT Margin %

5.49%

3.62%

4.79%

4.45%

5.09%

Net Interest Expenses

39

106

131

92

79

Net Interest Expenses Growth

+3,800%

+171.79%

+23.58%

-29.77%

-14.13%

Interest Expense, Total

-63

-44

-38

-52

-39

Interest And Investment Income

102

150

169

144

118

Other Non Operating Expenses, Total

713

1,792

776

1,014

959

EBT, Excl. Unusual Items

16,821

12,649

16,041

17,063

21,375

Gain (Loss) On Sale Of Assets

-880

-391

-129

-182

86

Other Unusual Items, Total

206

-565

-2,802

-909

-2,082

EBT, Incl. Unusual Items

15,929

11,767

13,125

15,881

19,078

EBT, Incl. Unusual Items Growth

+1.96%

-26.13%

+11.54%

+21%

+20.13%

EBT, Incl. Unusual Items Margin

5.44%

3.96%

4.15%

4.43%

4.77%

Income Tax Expense

6,729

5,079

6,025

6,638

7,670

Net Income to Company

9,200

6,688

7,100

9,243

11,408

Minority Interest

-21

9

-8

-9

-7

Net Income

9,179

6,697

7,092

9,234

11,401

Net Income Growth

+1.66%

-27.04%

+5.9%

+30.2%

+23.47%

Net Income Margin %

3.14%

2.25%

2.24%

2.57%

2.85%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

9,179

6,697

7,092

9,234

11,401

Basic EPS - Continuing Operations

259.09

189.03

201.46

262.86

324.63

Basic EPS - Continuing Operations Growth

+1.66%

-27.04%

+6.58%

+30.47%

+23.5%

Diluted EPS - Continuing Operations

259.09

189.03

201.46

262.86

324.63

Diluted EPS - Continuing Operations Growth

+1.66%

-27.04%

+6.58%

+30.47%

+23.5%

Basic Weighted Average Shares Outstanding

35.43

35.43

35.2

35.13

35.12

Diluted Weighted Average Shares Outstanding

35.43

35.43

35.2

35.13

35.12

Dividend Per Share

55

55

55

60

80

Dividend Per Share Growth

0%

0%

0%

+9.09%

+33.33%

EBITDA

24,513

19,430

24,059

25,796

31,222

EBITDA Growth

+1.59%

-20.74%

+23.82%

+7.22%

+21.03%

EBITDA Margin %

8.38%

6.54%

7.61%

7.19%

7.81%

EBIT